The investment plan includes an additional USD 13 billion investment to expand the company’s AI and cloud infrastructure in the country by 2030.
This takes...
Premiums Rise, Penetration Declines in FY 2023-24
As of the fiscal year 2023-24, India's insurance market has demonstrated robust growth. The total insurance premium increased...
Sector-specific customs duty proposals
Medicines and medical equipment
Three cancer drugs - namely Trastuzumab Deruxtecan, Osimertinib and Durvalumab - are fully exempted from custom duty.
...
Budget Estimates 2024-25:
Total receipts other than borrowings: Rs. 32.07 lakh crore.
Total expenditure: Rs. 48.21 lakh crore.
Net tax receipt: Rs. 25.83...